- Russia’s Sputnik-5 vaccine firm claims they will cost less than Pfizer and Moderna
- The official Twitter handle of the world’s first registered vaccine revealed this on Sunday
- Pfizer’s announced price is $ 19.50 per dose, while Moderna costs $ 25 to $ 37.
Corona virus infection is increasing rapidly throughout the world. With no cure for the epidemic, the only hope rests on the vaccines to come. Also, the big question is which vaccine will be so valuable. In such a situation, big news has come about Russia’s Sputnik-5 vaccine. Russia’s Sputnik-5 vaccine designed to fight the worldwide pandemic Covid-19 will cost the government less than Pfizer and Moderna. The official Twitter handle of the world’s first registered vaccine reported this on Sunday.
The tweet from the vaccine stated that Pfizer’s announced price per dose was $ 19.50 (Rs 1446.17) and the price of Moderna was $ 25 to $ 37 (Rs 1854.07-2744.02), according to a human being. The price will be $ 39 (Rs 2892.34) and 50 to 74 dollars (Rs 3708.13-5488.04). Every human will need two doses of Sputnik-5, Pfizer and Moderna. The price of Sputnik-5 will be much lower than these.
Russian vaccine price will be public next week
A Russian Direct Investment Fund (RDIF) spokesperson quoted the Tass news agency as saying in its report that the Russian vaccine price will be made public next week. When Sputnik-5 was officially registered before a large-scale diagnostic test, Russia became the first country to receive regulatory approval of the Kovid-19 vaccine in August. This vaccine has been developed by the Gamalia National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF).
This corona vaccine is about to come, the company told how much the price will be
Moderna vaccine Rs 1800-2700
On the other hand, Moderna Company has given information about the price of its vaccine for the first time. Its single dose will be priced between $ 25 to $ 37 (about Rs. 1800-2700). The price will also depend on how many orders have been received. Stephen Bensel, the company’s chief executive, gave this information. On 16 November, a European Commission official said that we have signed a deal with the company for millions of Moderna doses. A dose will cost less than $ 25. On this, Bensel said that no such deal has been done, yes it is definitely ready. We want to send the vaccine to Europe and negotiations are on. Moderna had stated that her vaccine was 94.5% successful in testing. (Input agency)